IL-17A/CTLA-8[Biotin], His & Avi, Human
IL-17A/CTLA-8[Biotin], His & Avi, Human

Immobilized IL-17A/CTLA-8[Biotin], His & Avi, Human, His Tag at 2 μg/ml (100 μl/well) on the streptavidin precoated plate(5 μg/ml). Dose response curve for Human IL-17R alpha, hFc Tag with the EC50 of 18.2 ng/ml determined by ELISA.

IL-17A/CTLA-8[Biotin], His & Avi, Human

IL-17A/CTLA-8[Biotin], His & Avi, Human on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.

IL-17A/CTLA-8[Biotin], His & Avi, Human

Human IL-17R alpha, hFc Tag captured on CM5 Chip via protein A can bind IL-17A/CTLA-8[Biotin], His & Avi, Human, His-Avi Tag with an affinity constant of 2.18 nM as determined in SPR assay (Biacore T200).

IL-17A/CTLA-8[Biotin], His & Avi, Human

Interleukin‑17A (IL‑17A), also known as CTLA‑8, is a 15‑20 kDa glycosylated cytokine that plays an important role in anti‑microbial and chronic inflammation. The six IL‑17 cytokines (IL‑17A‑F) are encoded by separate genes but adopt a conserved cystine knot fold.IL-17A is a ligand for IL17RA and IL17RC. The heterodimer formed by IL17A and IL17F is a ligand for the heterodimeric complex formed by IL17RA and IL17RC. Involved in inducing stromal cells to produce proinflammatory and hematopoietic cytokines.
Z04497
¥123,118.00

Ask us a question
Product Introduction
Species Human
Protein Construction
IL-17A/CTLA-8 (Gly24-Ala155)
Accession # Q16552-1		 His Avi
N-term C-term
Conjugate Biotin
Purity > 95% as determined by Bis-Tris PAGE
Endotoxin Level Less than 1EU per μg by the LAL method.
Biological Activity Measured by its binding ability in a functional ELISA. Test result was comparable to standard batch.
Expression System HEK293
Theoretical Molecular Weight 18.2 kDa
Apparent Molecular Weight Due to glycosylation, the protein migrates to 16-30 kDa based on Bis-Tris PAGE result.
Formulation Lyophilized from 0.22μm filtered solution in PBS (pH 7.4).
Reconstitution Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water.
Storage & Stability Upon receiving, the product remains stable for 6 months at -20℃ or below. Upon reconstitution, the product should be stable for 3 months at -80℃. Avoid repeated freeze-thaw cycles.

Examples
  • IL-17A/CTLA-8[Biotin], His & Avi, Human
    • IL-17A/CTLA-8[Biotin], His & Avi, Human

    Immobilized IL-17A/CTLA-8[Biotin], His & Avi, Human, His Tag at 2 μg/ml (100 μl/well) on the streptavidin precoated plate(5 μg/ml). Dose response curve for Human IL-17R alpha, hFc Tag with the EC50 of 18.2 ng/ml determined by ELISA.

  • IL-17A/CTLA-8[Biotin], His & Avi, Human
    • IL-17A/CTLA-8[Biotin], His & Avi, Human

    IL-17A/CTLA-8[Biotin], His & Avi, Human on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.

  • IL-17A/CTLA-8[Biotin], His & Avi, Human
    • IL-17A/CTLA-8[Biotin], His & Avi, Human

    Human IL-17R alpha, hFc Tag captured on CM5 Chip via protein A can bind IL-17A/CTLA-8[Biotin], His & Avi, Human, His-Avi Tag with an affinity constant of 2.18 nM as determined in SPR assay (Biacore T200).


Background
Target Background Interleukin‑17A (IL‑17A), also known as CTLA‑8, is a 15‑20 kDa glycosylated cytokine that plays an important role in anti‑microbial and chronic inflammation. The six IL‑17 cytokines (IL‑17A‑F) are encoded by separate genes but adopt a conserved cystine knot fold.IL-17A is a ligand for IL17RA and IL17RC. The heterodimer formed by IL17A and IL17F is a ligand for the heterodimeric complex formed by IL17RA and IL17RC. Involved in inducing stromal cells to produce proinflammatory and hematopoietic cytokines.
Synonyms CTLA-8; IL17; IL17A; IL-17CTLA-8; interleukin 17A

For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.